GENELUX Corp
GNLX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001231457
In the last 90 days, GENELUX Corp insiders filed 0 open-market purchases and 7 sales; 72 institutions reported holding it in 13F filings for Q2 2026, worth $29.5M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in GENELUX Corp as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +21 vs. Q4 2022
- Shares held
- 287.4K
- +287.4K vs. Q4 2022
- Total value
- $7.97M
- +$7.97M vs. Q4 2022
- New holders
- 21
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GNLX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 72 | $29.5M |
| Q1 2026 | 71 | $23.3M |
| Q4 2025 | 78 | $39.6M |
| Q3 2025 | 57 | $31.3M |
| Q2 2025 | 61 | $21.1M |
| Q1 2025 | 75 | $19.7M |
| Q4 2024 | 58 | $11.5M |
| Q3 2024 | 57 | $12.4M |
| Q2 2024 | 73 | $14.0M |
| Q1 2024 | 67 | $38.8M |
| Q4 2023 | 61 | $80.0M |
| Q3 2023 | 56 | $103.9M |
| Q2 2023 | 35 | $16.3M |
| Q1 2023 | 21 | $7.97M |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding GENELUX Corp; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 100 | $3.00K | 0.00% | +100 | New |
| Allworth Financial LP | 162 | $4.49K | 0.00% | +162 | New |
| UBS Group AG | 184 | $5.10K | 0.00% | +184 | New |
| Advisor Group Holdings, Inc. | 1,001 | $27.8K | 0.00% | +1,001 | New |
| Wells Fargo & Company | 1,018 | $28.2K | 0.00% | +1,018 | New |
| Tower Research Capital LLC (TRC) | 1,147 | $32.0K | 0.00% | +1,147 | New |
| Royal Bank of Canada | 2,000 | $55.0K | 0.00% | +2,000 | New |
| Morgan Stanley | 1,984 | $55.0K | 0.00% | +1,984 | New |
| Citigroup Inc | 3,031 | $84.1K | 0.00% | +3,031 | New |
| State Street Corp | 7,700 | $213.6K | 0.00% | +7,700 | New |
| Goldman Sachs Group Inc | 8,647 | $239.9K | 0.00% | +8,647 | New |
| Millennium Management LLC | 8,763 | $243.0K | 0.00% | +8,763 | New |
| Citadel Advisors LLC | 10,615 | $294.5K | 0.00% | +10,615 | New |
| Northern Trust Corp | 11,185 | $310.3K | 0.00% | +11,185 | New |
| BlackRock Inc. | 14,501 | $402.3K | 0.00% | +14,501 | New |
| Charles Schwab Investment Management Inc | 15,176 | $421.0K | 0.00% | +15,176 | New |
| Axxcess Wealth Management, LLC | 16,668 | $462.4K | 0.04% | +16,668 | New |
| Barclays PLC | 33,178 | $920.4K | 0.00% | +33,178 | New |
| Geode Capital Management, LLC | 37,709 | $1.05M | 0.00% | +37,709 | New |
| Hohimer Wealth Management, LLC | 44,940 | $1.25M | 0.36% | +44,940 | New |
| Vanguard Group Inc | 67,658 | $1.88M | 0.00% | +67,658 | New |